June 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences (GILD.O), opens new tab lenacapavir, a twice-yearly injection, for preventing HIV infection in adults ...
More for You Missouri becomes the latest state to try to quiet its citizens’ voices ‘The Love Boat’ cast sets sail again with reunion: The stars then and now Two College Football Teams Have Fired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback